| Paytronix 2026 Loyalty Report: Real-Time Personalization & AI-Powered Decisioning Drive Success |
Globe Newswire |
04/06 |
09:00 |
| Xulon Press announces new Christian living guide, Suit Up and Pray!, from author Marlene Dailey |
Globe Newswire |
04/06 |
09:00 |
| California Resources Corporation Schedules First Quarter 2026 Earnings Conference Call |
Globe Newswire |
04/06 |
09:00 |
| Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer |
Globe Newswire |
04/06 |
09:00 |
| Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026 |
Globe Newswire |
04/06 |
09:00 |
| Sify Technologies to announce Financial Results for FY 2025-26 on Monday, April 13, 2026 |
Globe Newswire |
04/06 |
08:58 |
| Gemini Space Station (GEMI) Facing Securities Class Action Following 75% Post-IPO Collapse – Hagens Berman |
Globe Newswire |
04/06 |
08:57 |
| ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating |
Globe Newswire |
04/06 |
08:57 |
| Coty Inc. (COTY) Facing Securities Class Action Amid Surprise YoY Deterioration in Operating Income, CEO Departure, Withdrawn Guidance -- Hagens Berman |
Globe Newswire |
04/06 |
08:57 |
| HTGC ALERT: Hercules Capital (HTGC) Facing Securities Class Action After Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman |
Globe Newswire |
04/06 |
08:54 |
| Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending -- Hagens Berman |
Globe Newswire |
04/06 |
08:50 |
| Driven Brands (DRVN) Facing Securities Class Action Alleging Pervasive Accounting Errors and Internal Control Failures Spanning 2023–2025 – Hagens Berman |
Globe Newswire |
04/06 |
08:49 |
| ODDITY Tech. (ODD) Shares Crater 49% Amid “Dislocation” Issue and Expected 30% Decline in Revenue; Securities Class Action Filed -- Hagens Berman |
Globe Newswire |
04/06 |
08:46 |
| CalPrivate Bank Strengthens Leadership Team With Appointment of Michael Pierron as Chief Operating Officer |
Globe Newswire |
04/06 |
08:45 |
| Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing |
Globe Newswire |
04/06 |
08:45 |
| APO INVESTOR ALERT: Hagens Berman Alerts Apollo Global Management (APO) Investors to Securities Class Action Stemming From “Epstein Files” Revelations |
Globe Newswire |
04/06 |
08:41 |
| Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman |
Globe Newswire |
04/06 |
08:40 |
| Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052 |
Globe Newswire |
04/06 |
08:35 |
| Pacific Office Automation Acquires Western Business Products, Expanding Coverage Across Northern California and Southern Oregon |
Globe Newswire |
04/06 |
08:34 |
| Eos Energy Enterprises (EOSE) Faces Securities Class Action Amid Analyst Questions Over Management’s Transparency, Shares Crater 39% -- Hagens Berman |
Globe Newswire |
04/06 |
08:33 |
| CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss |
Globe Newswire |
04/06 |
08:32 |
| NAVN INVESTOR ALERT: Securities Class Action Alleges Navan’s (NAVN) IPO Materials Omitted to Surge in Sales & Marketing Expenses – Hagens Berman |
Globe Newswire |
04/06 |
08:32 |
| Lakeland Fire + Safety to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Thursday, April 16, 2026 at 4:30 p.m. Eastern Time |
Globe Newswire |
04/06 |
08:31 |
| A. Duie Pyle Wins American Trucking Association’s President’s Trophy |
Globe Newswire |
04/06 |
08:30 |
| QURE 1-WEEK DEADLINE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data |
Globe Newswire |
04/06 |
08:23 |
